BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7446129)

  • 41. Immunosuppressive activities of peritoneal and splenic macrophages in murine leprosy: effect on lymphocyte transformation and tumor growth.
    Ha DK; Lawton JW; Gardner ID
    Microbiol Immunol; 1984; 28(7):793-806. PubMed ID: 6387401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble cytostatic factor(s) released from human monocytes. I. Production and effect on normal and transformed human target cells.
    Hammestrøm J
    Scand J Immunol; 1982 Mar; 15(3):311-8. PubMed ID: 7089490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 46. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia.
    Andreesen R; Osterholz J; Schulz A; Löhr GW
    Blut; 1983 Oct; 47(4):225-9. PubMed ID: 6616073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for granulocyte-mediated macrophage activation after C. parvum immunization.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 75(2):367-77. PubMed ID: 6831566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen.
    Sorrell TC; Lehrer RI; Cline MJ
    J Immunol; 1978 Feb; 120(2):347-52. PubMed ID: 340584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of macrophages grown in tumorous ascitic fluid.
    Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
    Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytostatic effect on tumour cells induced in human monocytes by mediators from BCG-stimulated lymphocytes and MLC.
    Unsgaard G; Hammerström J; Lamvik J
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):159-66. PubMed ID: 158283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct effects of Corynebacterium parvum and BCG on human monocyte-mediated tumour cell cytostasis in vitro.
    Hammerstrøm J
    Acta Pathol Microbiol Scand C; 1979 Aug; 87C(4):293-300. PubMed ID: 386712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
    McIntosh LC; Pugh-Humphreys RG; Thomson AW
    Br J Cancer; 1981 Apr; 43(4):496-504. PubMed ID: 7236491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
    Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
    Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peritoneal macrophage cytotoxicity induced by serum in vitro.
    Lejeune FJ; Beaumont L; Garcia Y; Regnier R
    Biomedicine; 1978; 28(1):48-54. PubMed ID: 667276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociation between tumour cell cytostatic and immuno-suppressive capacity of human monocytes activated with lymphokines.
    Unsgaard G; Hammerstrøm J; Lamvik J
    Acta Pathol Microbiol Immunol Scand C; 1982 Apr; 90(2):73-9. PubMed ID: 7080839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.
    Sakatani M; Ogura T; Masuno T; Kishimoto S; Yamamura Y
    Cancer Immunol Immunother; 1987; 25(2):119-25. PubMed ID: 2822242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.